Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
Gilead Sciences
Aditya Bardia; Hope S Rugo; Sara M Tolaney; Delphine Loirat; Kevin Punie; Mafalda Oliveira; Adam Brufsky; Kevin Kalinsky; Javier Cortés; Joyce O' Shaughnessy; Véronique Diéras; Lisa A Carey; Luca Gianni; Martine Piccart-Gebhart; Sibylle Loibl; Oh Kyu Yoon; Yang Pan; Scott Hofsess; See-Chun Phan; Sara A Hurvitz